Interferon therapy in multiple myeloma.
Alpha-interferon is an active agent in multiple myeloma. It proved to be beneficial in some but not all studies both in combined therapy with alkylating agents or as a single agent to prolong the plateau phase in patients in partial remission. The best strategy of administration has yet to be established.